Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51

Reference

• Kulasingam V, Pavlou MP, Diamandis EP. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer 2010; 10:371-8; PMID:20383179; http://dx.doi.org/10.1038/nrc2831
   PubMed Web of Science ®Google Scholar
• Cannistra SA. Cancer of the ovary. N Engl J Med 2004; 351:2519-2529; PMID:15590954; http://dx.doi.org/10.1056/NEJMra041842
   PubMed Web of Science ®Google Scholar
• Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, et al. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 2003; 64:382-94; PMID:12869643
   PubMed Web of Science ®Google Scholar
• Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 2008; 14:5519-30; PMID:18765544; http://dx.doi.org/10.1158/1078-0432.CCR-08-0197
   PubMed Web of Science ®Google Scholar
• Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 2008; 68:4347-51; PMID:18519695; http://dx.doi.org/10.1158/0008-5472.CAN-07-2970
   PubMed Web of Science ®Google Scholar
• Berdelle N, Nikolova T, Quiros S, Efferth T, Kaina B. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATMATR damage response in cancer cells. Mol Cancer Ther 2011; 10:2224-33; PMID:21998290; http://dx.doi.org/10.1158/1535-7163.MCT-11-0534
   PubMed Web of Science ®Google Scholar
• Lisewski AM, Quiros JP, Ng CL, Adikesavan AK, Miura K, Putluri N, Eastman RT, Scanfeld D, Regenbogen SJ, Altenhofen L, et al. Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate. Cell 2014; 158:916-28; PMID:25126794; http://dx.doi.org/10.1016/j.cell.2014.07.011
   PubMed Web of Science ®Google Scholar
• Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNKp38 MAPK and FasL. Arch Toxicol 2007; 81:719-28; PMID:17673978; http://dx.doi.org/10.1007/s00204-006-0169-y
   PubMed Web of Science ®Google Scholar
• Meeran SM, Katiyar S, Katiyar SK. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 2008; 229:33-43; PMID:18275980; http://dx.doi.org/10.1016/j.taap.2007.12.027
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y, Shao C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res 2009; 662:75-83; PMID:19159633; http://dx.doi.org/10.1016/j.mrfmmm.2008.12.009
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Q, Liu Z, Li B, Sun Z, Zhou H, Zhang X, Gong Y, Shao C. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat Res 2012; 734:20-9; PMID:22561209; http://dx.doi.org/10.1016/j.mrfmmm.2012.04.005
   PubMed Web of Science ®Google Scholar
• Liu Q, Jiang H, Liu Z, Wang Y, Zhao M, Hao C, Feng S, Guo H, Xu B, Yang Q, et al. Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51. PLoS ONE 2011; 6:e23427; PMID:21858113; http://dx.doi.org/10.1371/journal.pone.0023427
   PubMed Web of Science ®Google Scholar
• Mao Z, Seluanov A, Jiang Y, Gorbunova V. TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination. Proc Natl Acad Sci USA 2007; 104:13068-73; PMID:17670947; http://dx.doi.org/10.1073/pnas.0702410104
   PubMed Web of Science ®Google Scholar
• Reichert S, Reinboldt V, Hehlgans S, Efferth T, Rödel C, Rödel F. A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother Oncol 2012; 103:394-401; PMID:22560712; http://dx.doi.org/10.1016/j.radonc.2012.03.018
   PubMed Web of Science ®Google Scholar
• Luo J, Zhu W, Tang Y, Cao H, Zhou Y, Ji R, Zhou X, Lu Z, Yang H, Zhang S, et al. Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo. Radiat Oncol 2014; 9:84; PMID:24666614; http://dx.doi.org/10.1186/1748-717X-9-84
   PubMed Web of Science ®Google Scholar
• Klein HL. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst) 2008; 7:686-93; PMID:18243065; http://dx.doi.org/10.1016/j.dnarep.2007.12.008
   PubMed Web of Science ®Google Scholar
• Sørensen CS, Hansen LT, Dziegielewski J, Syljuåsen RG, Lundin C, Bartek J, Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 2005; 7:195-201; PMID:15665856
   PubMed Web of Science ®Google Scholar
• Schild D, Wiese C. Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res 2010; 38:1061-70; PMID:19942681; http://dx.doi.org/10.1093/nar/gkp1063
   PubMed Web of Science ®Google Scholar
• Tichy ED, Pillai R, Deng L, Tischfield JA, Hexley P, Babcock GF, Stambrook PJ. The abundance of Rad51 protein in mouse embryonic stem cells is regulated at multiple levels. Stem Cell Res 2012; 9:124-34; PMID:22705496; http://dx.doi.org/10.1016/j.scr.2012.05.004
   PubMed Web of Science ®Google Scholar
• Simandlova J, Zagelbaum J, Payne MJ, Chu WK, Shevelev I, Hanada K, Chatterjee S, Reid DA, Liu Y, Janscak P, et al. FBH1 helicase disrupts RAD51 filaments in vitro and modulates homologous recombination in mammalian cells. J Biol Chem 2013; 288:34168-80; PMID:24108124; http://dx.doi.org/10.1074/jbc.M113.484493
   PubMed Web of Science ®Google Scholar
• Wei N, Shi Y, Truong LN, Fisch KM, Xu T, Gardiner E, Fu G, Hsu YS, Kishi S, Su AI, et al. Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage. Mol Cell 2014; 56:323-32; PMID:25284223; http://dx.doi.org/10.1016/j.molcel.2014.09.006
   PubMed Web of Science ®Google Scholar
• Huang JW, Wang Y, Dhillon KK, Calses P, Villegas E, Mitchell PS, Tewari M, Kemp CJ, Taniguchi T. Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity. Mol Cancer Res. 2013; 11:1564-73; PMID:24088786
   PubMed Web of Science ®Google Scholar
• Shan W, Mercado-Uribe I, Zhang J, Rosen D, Zhang S, Wei J, Liu J. Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications. Cell Cycle 2012; 11:2107-13; PMID:22592533; http://dx.doi.org/10.4161/cc.20544
   PubMed Web of Science ®Google Scholar
• Guo H, Liu Z, Xu B, Hu H, Wei Z, Liu Q, Zhang X, Ding X, Wang Y, Zhao M, et al. Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage. Aging Cell 2013; 12:1110-21; PMID:23869868; http://dx.doi.org/10.1111/acel.12138
   PubMed Web of Science ®Google Scholar